...
首页> 外文期刊>Journal of Clinical Pharmacy and Therapeutics >Use of indapamide in hospital and community clinics and its effect on plasma potassium in Chinese patients.
【24h】

Use of indapamide in hospital and community clinics and its effect on plasma potassium in Chinese patients.

机译:吲达帕胺在医院和社区诊所中的使用及其对中国患者血浆钾的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: To investigate the usage pattern of indapamide and other antihypertensive drugs in patients attending a community-based government outpatient clinic (GOPC) or a hospital-based specialist clinic (SC). The plasma potassium concentrations of patients receiving indapamide and other diuretics were also examined. METHOD: Prescriptions from the SC and the GOPC were reviewed and collected during January 1998. Patients' plasma potassium concentrations and the date of initiation of each medication were retrieved from the hospital computer databases at SC. An age- and sex-matched control group of patients on non-diuretic antihypertensive drugs was identified. RESULTS: A total of 1648 and 773 prescriptions were collected from the SC during a 1-week period and GOPC during a 1-month period, respectively. Approximately half (45%) of the patients received antihypertensive treatment. Indapamide was five times more frequently prescribed in GOPC than SC (84.7 vs. 17.7%, P<0.001). Calcium channel blocking agents were the commonest antihypertensive drugs used in both clinics. The mean plasma potassium concentration of patients taking indapamide was lower than that of the control group (P = 0.037). Multiple linear regression analysis showed that consumption of indapamide (P =0.002) and duration of diuretic therapy (P = 0.023) were significantly related to changes in plasma potassium concentrations [multiple regression equation for potassium level = 4.09-0.145 (thiazide = 1)-0.377 (indapamide = 1) -0.00468 (duration of diuretic therapy in months)]. CONCLUSION: Indapamide was used extensively in the community clinic and less in the hospital-based outpatient clinic. Patients receiving indapamide had a significantly lower plasma potassium concentration as compared to other diuretics or antihypertensive groups and this was predicted by a multiple linear regression model. Monitoring plasma electrolytes before initiation of indapamide treatment and at regular intervals thereafter is essential for detecting the hypokalaemia that may occur in Chinese patients.
机译:目的:调查吲达帕胺和其他降压药在社区社区政府门诊(GOPC)或医院专科诊所(SC)的患者中的使用模式。还检查了接受吲达帕胺和其他利尿剂治疗的患者的血浆钾浓度。方法:在1998年1月审查并收集了SC和GOPC的处方。从SC的医院计算机数据库中检索了患者的血浆钾浓度和每种药物的起始日期。确定了使用非利尿降压药的年龄和性别匹配的对照组。结果:在1周的时间里从SC收集了1648份处方,在1个月的时间里从GOPC收集了773张处方。大约一半(45%)的患者接受了降压治疗。在GOPC中,吲达帕胺处方的频率是SC的五倍(84.7比17.7%,P <0.001)。钙通道阻滞剂是两家诊所中最常用的降压药。服用吲达帕胺的患者的平均血钾浓度低于对照组(P = 0.037)。多元线性回归分析显示,吲达帕胺的消耗量(P = 0.002)和利尿剂治疗的持续时间(P = 0.023)与血浆钾浓度的变化显着相关[钾水平的多元回归方程= 4.09-0.145(噻嗪= 1)- 0.377(吲达帕胺= 1)-0.00468(利尿剂治疗时间(以月为单位))。结论:吲达帕胺在社区诊所中被广泛使用,而在医院门诊中则较少使用。与其他利尿剂或降压组相比,接受吲达帕胺治疗的患者血浆钾浓度明显降低,这是通过多元线性回归模型预测的。在开始吲达帕胺治疗之前和之后定期监测血浆电解质对于检测中国患者可能发生的低钾血症至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号